Latest Mergers And Acquisitions News

Culpeo Minerals reports significant progress in copper exploration across Chile with promising drilling results and a strategic acquisition of the Jupiter Project.

Locksley Resources has advanced its Mojave Project with critical drilling permits secured, a strategic $1.47 million capital raise, and a new U.S. OTCQB listing, setting the stage for maiden drilling campaigns targeting rare earths and antimony.

Capricorn Metals reported a strong June quarter with Karlawinda gold production meeting FY25 guidance and announced it is now debt free and unhedged. Development at Mt Gibson and Karlawinda Expansion projects progresses, supported by record cash flow.

Solara Minerals has identified multiple compelling drill targets for gold and copper at its newly acquired Degrussa West Project following a detailed electromagnetic survey. The project lies near major regional deposits, setting the stage for an exciting exploration phase.

Tlou Energy Limited’s latest quarterly cash flow report reveals a cautious financial position with A$2.74 million in available funding, supporting approximately 2.5 quarters of operations as exploration activities continue.

S2 Resources advances exploration across multiple Australian projects with promising gold and base metal anomalies, while bolstering its balance sheet through a successful A$3.5 million capital raise.

Peak Minerals reports a significant expansion of heavy mineralisation at its Minta Rutile Project in Cameroon, alongside a $3.5 million strategic investment that fully funds its 2025 exploration plans.

VanEck Global Defence ETF, launched in September 2024, has reported a solid AUD 2.8 million profit in its first interim financial results ending January 2025, marking a promising start for the defence-focused fund.

Tolu Minerals reports significant progress at its Tolukuma Gold Mine, unveiling infrastructure upgrades and a $14.3 million exploration program aimed at boosting production and extending mine life.

Donaco International’s Q4 FY2025 results reveal a revenue dip driven by geopolitical tensions at its Star Vegas casino, while its Vietnam hotel posts gains. Meanwhile, the company’s proposed acquisition by On Nut Road Limited moves closer to shareholder approval.

Noxopharm has initiated its HERACLES clinical trial for SOF-SKN, marking a key milestone for its Sofra platform, while deepening partnerships and actively seeking new funding to sustain development.

Opthea has discontinued its sozinibercept program after Phase 3 trial failures, leading to drastic staff cuts and a sharp decline in cash reserves amid ongoing funding negotiations.